Ansun Biopharma

Ansun Biopharma is a biotech company in San Diego, United States, founded in 2003. It has raised $85.0M across 1 round, most recently an $85.0M Series A in May 2018.

Leading the effort to combat cancer and viral infections

Employees
11–50
Founded
2003
Business Model
B2B
Total Funding
$85.0M
Last Round
$85.0M Series AMay 2018
Rounds
1

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 1 funding round and 1 investor for this company. The full record is or through the API.

About

Ansun Biopharma is a clinical-stage company developing recombinant therapeutic proteins for severe viral infections that lack existing treatment options. A team of about 25 scientists and doctors in San Diego invented DAS181, a recombinant fusion protein designed to block sialic acid-dependent viruses—including influenza, parainfluenza, metapneumovirus, and enterovirus 68—from entering human respiratory epithelial cells by targeting the host rather than the mutating virus. CEO Dr. Nancy Chang, who previously co-founded Tanox, has led Ansun since 2017.

Summary

It lists 11–50 employees. It has raised $85.0M in total across 1 round, most recently a $85.0M Series A round in May 2018. Investors include Lilly Asia Ventures.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Data from Indexed.vcUpdated
Series ASeries AMay 2018
$85.0M

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
ParexelAcquired

One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...

Raleigh, United States10001+Biotech
Private EquityTotal funding$5.0BJun 2017
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Ansun Biopharma on Indexed.vc
<a href="https://indexed.vc/companies/ansun-biopharma"><img src="https://indexed.vc/api/badge/company/ansun-biopharma" alt="Ansun Biopharma on Indexed.vc" width="260" height="76" /></a>